Becton, Dickinson and Company announced some preliminary fiscal Q4 results recently. Read why I am reaffirming my prior buy rating on BDX stock.
Fiduciary Management Inc. (FMI), an independent money management firm, released its third-quarter 2025 investor letter. A ...
Nisha Thakrar, investment specialist at Nedgroup Investments, selects three undervalued stocks with long-term growth ...
Medical Device Network on MSN
BD launches AI-powered Incada Platform for healthcare connectivity
BD has launched the Incada Connected Care Platform, an AI-powered cloud-based system designed to integrate data from the ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Expanding your horizons and considering neglected sectors can help you identify bargain opportunities while defending your ...
Becton Dickinson (BDX) is making headlines following news of a multi-year partnership with Opentrons Labworks. The collaboration centers on integrating robotic liquid-handling automation into BD's ...
Oct 15 (Reuters) - Becton Dickinson (BDX.N), opens new tab said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the ...
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Becton, Dickinson and Co. (NYSE:BDX) is a multinational medical technology company that ...
Becton Dickinson said on Wednesday that its Chief Financial Officer Chris DelOrefice will depart the company, effective December 5, after four years at the medical device maker. Shares of the company ...
The latest price target for Becton Dickinson (NYSE:BDX) was reported by RBC Capital on October 16, 2025. The analyst firm set a price target for $211.00 expecting BDX to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results